Arcutis Biotherapeutics Stock Predictions

Is the Traditional House Obsolete?

Disclosure: *This is a paid advertisement for Boxabl's Regulation A offering. Please read the offering circular at invest.boxabl.com. This is a message from Boxabl.

Sell

ARQT
Arcutis Biotherapeutics

Last Price:

$13.58

Seasonality Move:

-5.71%

7 Day Trial

ALL ACCESS PASS

$ 7

Your Portfolio's Boring. This Company Isn't And It's Early

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering. Please read the offering circular and related risks at invest.radintel.ai. *RAD Intel recently received their ticker reservatio

Arcutis Biotherapeutics Stock Forecast

Over the next 52 weeks, Arcutis Biotherapeutics has on average historically fallen by 8% based on the past 5 years of stock performance.
Arcutis Biotherapeutics has fallen lower in 4 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 80%
Is Arcutis Biotherapeutics Stock Undervalued?

The current Arcutis Biotherapeutics [ARQT] share price is $14.14. The Score for ARQT is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
ARQT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Arcutis Biotherapeutics Stock Go Up Next Year?

Over the next 52 weeks, Arcutis Biotherapeutics has on average historically fallen by 8% based on the past 5 years of stock performance.

Arcutis Biotherapeutics Stock Rating

Sell

Arcutis Biotherapeutics (ARQT) is a Sell

Is Arcutis Biotherapeutics overpriced?

Arcutis Biotherapeutics has fallen lower in 4 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 80%

Arcutis Biotherapeutics Stock Price History

Is ARQT stock going to rise?

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ARQT is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

arcutis.com

52-Week Data

52-Week High:

17.75

52-Week Low:

6.99

Prediction Charts

Market Cap:

1.7B

Price in USD:

14.14

Volume:

2.1M

Beta:

1.23

Technical Analysis

SMA50:

14.67

SMA100:

14.14

SMA200:

12.28

52-Wk Change:

54.37%

Stock Predictions

Is Arcutis Biotherapeutics stock public?

Yes, Arcutis Biotherapeutics is a publicly traded company.
What is the Arcutis Biotherapeutics stock quote today?

The Arcutis Biotherapeutics stock price is 14.14 USD today.
How to buy Arcutis Biotherapeutics stock online?

You can buy Arcutis Biotherapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
May-7	14.24	13.70	14.34	12.42
May-8	13.63	13.52	14.21	13.43
May-9	13.50	13.53	13.93	13.15
May-12	13.51	14.39	14.61	13.50
May-13	14.53	13.82	14.56	13.63
May-14	13.94	13.60	14.13	13.54
May-15	13.55	13.63	13.78	13.31
May-16	13.79	14.11	14.19	13.57
May-19	13.78	14.64	14.67	13.66
May-20	14.70	14.51	14.75	14.14
May-21	14.31	13.76	14.38	13.57
May-22	13.74	13.66	14.10	13.49
May-23	13.49	13.98	14.00	13.27
May-27	14.26	14.14	14.30	13.73

Arcutis Biotherapeutics Earnings

Arcutis Biotherapeutics Earnings Report: Per Share Arcutis Biotherapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Arcutis Biotherapeutics Forecast Revenue Growth

Arcutis Biotherapeutics Stock Analysis: Historical quarterly revenues per share for Arcutis Biotherapeutics and historical quarterly revenue growth:

Analysts estimate an earnings increase this quarter of $0.30 per share, an increase next quarter of $0.17 per share, an increase this year of $0.79 per share, and an increase next year of $0.72 per share.

* Arcutis Biotherapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.